The future of medicine is based on intensive research. Innovations from genetic research and digitization, for example, are revolutionizing medicine and healthcare more than ever before. Strong entrepreneurs are also needed to turn scientists’ results into real products and help to improve patients’ diagnosis, prevention, therapy, nursing and rehabilitation. These stories provide insights into the top research and development in central Hessen and show the latest trends – always for the benefit of patients all over the world.
mRNA: this “new” technology has provided the fast track to a vaccine in the fight against Corona. The technology makes it possible to quickly adapt the vaccine to virus variants – and it may be groundbreaking for other applications in the pharmaceutical field.
Digitalization is making healthcare both more efficient and better. Central Hessen’s researchers and industry are pushing the future of digital healthcare.
In Central Hesse, a strong network of industry and research creates special attention and help for patients with rare diseases. Sabine Pitschula is one of them. On the occasion of Rare Disease Day on February 28, presenter Dr. Eckart von Hirschhausen spoke with her and medical experts from a competence network about the often long … Read more
After 15 minutes, surfaces can become 99 percent germ-free after: Chemist Dr. Klaus Schepers explains how this occurs. Schepers is the founder of Munditech, which produces plant-based, antimicrobial coatings.
Scientists are racing to get the Corona pandemic under control. Research institutes and companies from Central Hessen are making major contributions and developing new long-term research strategies.
Why is donating blood plasma so important? Plasma serves as a raw material for the production of life-saving drugs. To ensure the production of these therapeutics, plasma donors are urgently needed – especially, now, during the pandemic.
At the Center for Unknown and Rare Diseases (ZusE) at Marburg University Hospital, patients find help from Prof. Juergen Schaefer.
DFG President Prof. Dr. Katja Becker has dedicated her life as a researcher to one goal in particular: to develop new drugs and diagnostics against poverty-associated and neglected infectious diseases.